Concepedia

Wan Feng

WF

Statistics

Publications

7

Citations

211

H-Index

7

Active since

2015

Affiliations

Nanjing University of Chinese Medicine(Current)

Nanjing Drum Tower Hospital

Nanjing Medical University

Jiangsu Province Hospital

Wan Feng is an author at Nanjing University of Chinese Medicine specializing in oncology, tumor biology, and cell death.

ORCID

Top concepts

Publications per year

2015–2023

7

Publications

7

Metformin inhibits gastric cancer via the inhibition of HIF1α/PKM2 signaling.

Guangxia Chen, Wan Feng, Shu Zhang et al. · PubMed · 2015 · 58 citations · Full text

, , +14

Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells

Wan Feng, Dawei Cai, Bin Zhang et al. · Biomedicine & Pharmacotherapy · 2015 · 50 citations

, , +10

7,8‑Dihydroxyflavone activates Nrf2/HO‑1 signaling pathways and protects against osteoarthritis

Dawei Cai, Wan Feng, Jun Liu et al. · Experimental and Therapeutic Medicine · 2019 · 24 citations · Full text

Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential markers for ulcerative colitis: a retrospective study

Wan Feng, Yajun Liu, Lei Zhu et al. · BMC Gastroenterology · 2022 · 24 citations · Full text

C‐reactive protein/albumin ratio and <scp>IL</scp>‐6 are associated with disease activity in patients with ulcerative colitis

Wan Feng, Lei Zhu, Yajun Liu et al. · Journal of Clinical Laboratory Analysis · 2023 · 19 citations · Full text

1–5 of 7